About Us

Contact Us

Global Headquarters
Schering-Plough Corporation World Headquarters
2000 Galloping Hill Road
Kenilworth, N.J. 07033-0530
United States

Telephone: +1 (908) 298-4000

Directions to our New Jersey locations

Partnerships

In today's competitive pharmaceutical industry, strategic licensing agreements and partnerships are key to maintaining a balanced portfolio of products and technologies. To partner with us, please contact a representative in one of the following areas:

Human Prescription	Consumer Health Care
Animal Health	Mergers & Acquisitions

Growing Stronger, Growing Better

Our combination with Organon BioSciences is a transformational step on Schering-Plough’s continuing journey as we build a high-performance company for the long term.

Basic Facts & Figures

World Headquarters
2000 Galloping Hill Road, Kenilworth, N.J. 07033-0530

Chairman and CEO
Fred Hassan

Number of employees
51,000

Net sales (2008)
$18.5 billion

Business Operations in
more than 140 countries

Largest-selling products
VYTORIN*, ZETIA*, REMICADE, NASONEX, TEMODAR

R&D investment (2008)
$3.5 billion

Areas of research
cardiovascular disease, central nervous system disorders, immunology and infectious disease, oncology, respiratory diseases and women's health

*VYTORIN and ZETIA are managed through a joint venture with Merck & Co., Inc. Schering-Plough accounts for the joint venture under the Equity method. Total cholesterol joint venture sales were $4.5 billion in 2008.

Schering-Plough in Oceania

Australia
Schering-Plough Pty Limited
66 Waterloo Road
North Ryde
NSW 2113
Australia

Telephone: (61)-2 8988 8000
Website: www.schering-plough.com.au

Australia
91-105 Harpin Street Bendigo East
Victoria, Australia, 3350

Telephone: +61 (0) 3 5440 9888

New Zealand
36 Kitchener Street
Level 15
Auckland 1010, New Zealand

Telephone: +64 9 375 9210

New Zealand
33 Whakatiki Street
Upper Hutt, New Zealand

Telephone: +64 4 439 1900

Schering-Plough Corporation